Mizuho Medy Co.,Ltd. (TYO:4595)
Japan · Delayed Price · Currency is JPY 1,734.00
+1.00 (0.06%)
Aug 25, 2026, 3:30 PM JST
Mizuho Medy Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 13,057 | 10,825 | 11,246 | 10,134 | 8,702 | 4,326 |
Cash & Short-Term Investments | 13,057 | 10,825 | 11,246 | 10,134 | 8,702 | 4,326 |
Cash Growth | 5.60% | -3.74% | 10.97% | 16.46% | 101.16% | 7911.11% |
Receivables | 1,541 | 6,222 | 4,543 | 4,399 | 6,387 | 4,007 |
Inventory | 3,557 | 2,404 | 2,047 | 1,596 | 1,267 | 1,265 |
Other Current Assets | 113 | 129 | 162 | 160 | 144 | 62 |
Total Current Assets | 18,268 | 19,580 | 17,998 | 16,289 | 16,500 | 9,660 |
Property, Plant & Equipment | 2,236 | 2,264 | 2,271 | 2,251 | 2,153 | 2,099 |
Long-Term Investments | 447 | 21 | 29 | 16 | 17 | 18 |
Other Intangible Assets | 33 | 36 | 10 | 11 | 14 | 12 |
Long-Term Deferred Tax Assets | - | 472 | 419 | 379 | 417 | 402 |
Other Long-Term Assets | 2 | 2 | 2 | 2 | 1 | 1 |
Total Assets | 20,986 | 22,375 | 20,729 | 18,948 | 19,102 | 12,192 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 683 | 482 | 518 | 513 | 738 | 504 |
Accrued Expenses | 70 | 141 | 157 | 125 | 118 | 86 |
Current Income Taxes Payable | 252 | 1,831 | 1,433 | 1,425 | 2,866 | 2,636 |
Current Unearned Revenue | - | - | - | - | - | 2 |
Other Current Liabilities | 377 | 206 | 179 | 216 | 199 | 107 |
Total Current Liabilities | 1,382 | 2,660 | 2,287 | 2,279 | 3,921 | 3,335 |
Pension & Post-Retirement Benefits | 1,049 | 1,029 | 1,087 | 992 | 897 | 827 |
Other Long-Term Liabilities | 1 | 2 | 2 | 2 | 2 | 2 |
Total Liabilities | 2,432 | 3,691 | 3,376 | 3,273 | 4,820 | 4,164 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 464 | 464 | 464 | 464 | 464 | 464 |
Additional Paid-In Capital | 274 | 274 | 274 | 274 | 274 | 274 |
Retained Earnings | 17,817 | 17,947 | 16,616 | 14,938 | 13,545 | 7,291 |
Treasury Stock | -2 | -2 | -2 | -2 | -1 | -1 |
Comprehensive Income & Other | 1 | 1 | 1 | 1 | - | - |
Shareholders' Equity | 18,554 | 18,684 | 17,353 | 15,675 | 14,282 | 8,028 |
Total Liabilities & Equity | 20,986 | 22,375 | 20,729 | 18,948 | 19,102 | 12,192 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 13,057 | 10,825 | 11,246 | 10,134 | 8,702 | 4,326 |
Net Cash Growth | 5.60% | -3.74% | 10.97% | 16.46% | 101.16% | - |
Net Cash Per Share | 685.46 | 568.28 | 590.38 | 1064.00 | 913.65 | 454.20 |
Filing Date Shares Outstanding | 19.05 | 19.05 | 19.05 | 9.52 | 9.52 | 9.52 |
Total Common Shares Outstanding | 19.05 | 19.05 | 19.05 | 9.52 | 9.52 | 9.52 |
Working Capital | 16,886 | 16,920 | 15,711 | 14,010 | 12,579 | 6,325 |
Book Value Per Share | 974.03 | 980.86 | 910.98 | 1645.77 | 1499.51 | 842.88 |
Tangible Book Value | 18,521 | 18,648 | 17,343 | 15,664 | 14,268 | 8,016 |
Tangible Book Value Per Share | 972.30 | 978.97 | 910.46 | 1644.61 | 1498.04 | 841.62 |